LatestIP And Trademarks 31 October 2026
India Patent Moves Impact Health, Heritage, AI and Design
India blocks a TB drug patent, cutting treatment costs, while Assam pushes heritage protection with new historic site atlas. Wikimedia joins the NYT‑OpenAI copyright clash, highlighting India's AI law gap. Korean patents boost GIX vehicle navigation and Lightbridge nuclear fuel tech. Legistify launches a trademark renewal tool, CEED 2027 design exam registration nears deadline, and Hyundai trademarks a sub‑4‑meter electric SUV for a 2027 launch.
- TB drug patent rejected in India – The Indian Express explains how the decision keeps prices low for patients. Read more
- Assam heritage preservation plan – The Times of India reports new resolutions, an atlas of historic sites and GI‑tagged products despite funding gaps. Read more
- Wikimedia joins NYT vs OpenAI case – Times Now discusses the copyright battle’s relevance for India’s unsettled AI rules. Read more
- GIX subsidiary secures South Korean navigation patent – Investing.com notes expanded IP protection for hospital logistics. Read more
- Lightbridge gets Korean patent for nuclear fuel design – Investing.com highlights the new grant. Read more
- Legistify launches IP module for trademark renewals – ANI reports built‑in WIPO search for multi‑market protection. Read more
- CEED 2027 design exam registration deadline – Shiksha and Jagran Josh remind candidates of the closing date and late fees. Read more Shiksha | Read more Jagran Josh
- Hyundai trademarks sub‑4 m electric SUV name – Mint reports the Ioniq P name filed in India ahead of a 2027 launch. Read more
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.
